Hookipa Biotech

Drug development oncology and autoimmune diseases


HBM contact: Dr Michael Buschle

Company status: private

Hookipa Biotech AG is a privately held, clinical stage biotech company aiming to develop best-in-class active immunization therapies for infectious diseases and oncology.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171